• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

New Covid-19 treatment drug available for use in Ireland

FirstWordPharmaJanuary 28, 2022

Tag: COVID-19 , Xevudy , antibody

Ireland has agreed a supply deal for GlaxoSmithKline's COVID-19 antibody treatment Xevudy (sotrovimab), reported The Irish Times.

The UK drugmaker and its partner Vir Biotechnology agreed a contract last year with the EU to supply up to 220,000 doses of Xevudy for use by member states.

It is authorised for use in over-12s with COVID-19 who do not need supplemental oxygen and who are at greater risk of developing severe illness.

In January, the Irish government agreed to spend €90 million on antiviral and monoclonal antibody treatments made by Pfizer, GlaxoSmithKline and Merck & Co.

Previous:China's Walvax says has most participants for large mRNA COVID vaccine trial

Next:AG Nessel Launches Investigation into Excessive Insulin Prices, Intends to Challenge MSC Decisions Impacting Consumer Protection

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

New Covid-19 treatment drug available for use in Ireland - PharmaSources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Measles virus antibody test strip

Measles virus antibody test strip
Arch-insect antibody test strip

Arch-insect antibody test strip
SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)

SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)
Heapatitis A IgM antibody test strip

Heapatitis A IgM antibody test strip
Cytomegaloovirus antibody test strip

Cytomegaloovirus antibody test strip
Helicobacter pylori antibody test strip

Helicobacter pylori antibody test strip
Syphilis leptospira antibody test strip

Syphilis leptospira antibody test strip
Heapatitis C virus antibody test strip

Heapatitis C virus antibody test strip
Syphilis leptospira antibody test strip

Syphilis leptospira antibody test strip
Silica-based Aqueous SEC (GFC) Column for Analysis of Antibody Protein: PROTEIN LW

Silica-based Aqueous SEC (GFC) Column for Analysis of Antibody Protein: PROTEIN LW

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service